Jeantet advises DREAMPATH DIAGNOSTICS on the acquisition of a stake by SUMMIT PARTNERS
Paris, July 16, 2025 – Jeantet advised Dreampath Diagnostics, a group specializing in automation and traceability of anatomical pathology samples, on Summit Partners’ acquisition of a minority stake. The transaction aims to accelerate Dreampath Diagnostics’ international growth and strengthen its offering of solutions for digitizing laboratory processes. Founded in 2012, the Dreampath Diagnostics group offers […]
Paris